Description
Specifications:
Letrozole
Company: Hilma Biocare
Active Half-life (Days): 2-3 days
Group: Aromatase inhibitor
Subgroup: Oral/tablets
Dosage: 2.5 mg/tab
Application (Men): 0.5 to 1 mg throughout 1 to 3 days
Product pack: 30 tab.
Content (active): Letrozole
Retains water: No
Aromatization: No
Product Description
Letrozole is an antitumor agent, a non-steroidal selective inhibitor of the aromatase enzyme. Widely used in medicine as a part of post-menopausal therapy in women and breast cancer treatment. Among athletes gained recognition for strong anti-estrogenic properties and raised muscle definition. Like Anastroloze(Arimidex), its effect is up to 5 times stronger, eliminating adverse reactions from anabolic steroid use. Letrozole can suppress estrogen levels in the body, almost wholly shielding from raised estradiol levels.
Effects:
By using Femara athletes can almost wholly suppress estrogen level in the body and protects themselves against aromatization.
Side-Effects:
The most common side effects attributed to Femara are skin rash, nausea, abdominal pain, fatigue, dizziness, headache, raised Low-density cholesterol levels and liver enzymes.
Protection:
Preliminary blood test should be conducted before using Femara. Results in colossal estradiol reduction and increasing the effectiveness of your cycle. Letrozole served as an anti-estrogenic drug and was used as a part of PCT.
Stacking:
Antiestrogen is most effective during PCT but can be stacked with clomiphene or other steroids as a part of the cycle.
Reviews
There are no reviews yet.